| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Consultant's View on the Role of Bayesian Differential Diagnosis in the Safety Assessment of Pharmaceuticals
|
Naranjo, Claudio A.
|
|
1992
|
26 |
4 |
p. 593-601
|
artikel
|
| 2 |
An Expert System for Prediction of Chemical Toxicity
|
Hickey, James P.
|
|
1992
|
26 |
4 |
p. 487-495
|
artikel
|
| 3 |
An Industry Perspective on the State of Confusion in International ADR Reporting: Current Requirements and Attempts at Standardization
|
Gordon, Arnold J.
|
|
1992
|
26 |
4 |
p. 573-581
|
artikel
|
| 4 |
Armor: ICI's Automated Tracking System for Adverse Events from Clinical Trials
|
Klinger, Elizabeth J.
|
|
1992
|
26 |
4 |
p. 537-543
|
artikel
|
| 5 |
Causality Assessment in the European Pharmaceutical Industry: Presentation of the Preliminary Results of a New Method
|
Bénichou, Christian
|
|
1992
|
26 |
4 |
p. 589-592
|
artikel
|
| 6 |
Clinical Trial Adverse Drug Experience Reporting Requirements in the Major Countries and a Simplified Approach toward Meeting These Requirements
|
Talbott, Max W.
|
|
1992
|
26 |
4 |
p. 519-525
|
artikel
|
| 7 |
Computer-Aided Assessment of the Adverse Effects of Antiepileptic Drugs
|
Mabry, Michael E.
|
|
1992
|
26 |
4 |
p. 505-517
|
artikel
|
| 8 |
Data Management Team-Driven Approach to Handling International Clinical Data
|
Hudson, Ronald Carlisle
|
|
1992
|
26 |
4 |
p. 659-665
|
artikel
|
| 9 |
Did My Drug Cause This? a Biostatistical Perspective
|
Von Tress, Mark S.
|
|
1992
|
26 |
4 |
p. 565-572
|
artikel
|
| 10 |
Did My Drug Cause This? an Academic Perspective
|
Knodel, Leroy C.
|
|
1992
|
26 |
4 |
p. 559-564
|
artikel
|
| 11 |
EEC Pharmacovigilance and the Pharmaceutical Industry: Common Market, Common Rules?
|
Bénichou, Christian
|
|
1992
|
26 |
4 |
p. 473-476
|
artikel
|
| 12 |
Good Clinical Practice: EC Expectations Education, Self-Regulation, or Imposition?
|
Jefferys, David B.
|
|
1992
|
26 |
4 |
p. 609-613
|
artikel
|
| 13 |
Guest Editor's Note
|
Herman, Raymond L.
|
|
1992
|
26 |
4 |
p. 471
|
artikel
|
| 14 |
Issues with Causality Assessment: A Personal Perspective
|
Schneiweiss, Fred
|
|
1992
|
26 |
4 |
p. 549-551
|
artikel
|
| 15 |
Managing Adverse Reaction Information
|
Mann, Ronald D.
|
|
1992
|
26 |
4 |
p. 583-587
|
artikel
|
| 16 |
Market Failure, Information Imperfections, and Cost-Effectiveness Analysis
|
Hoerger, Thomas J.
|
|
1992
|
26 |
4 |
p. 647-654
|
artikel
|
| 17 |
New Designs for Stability Testing Programs: Matrix or Factorial Designs. Authorities' Viewpoint on the Predictive Value of Such Studies
|
Helboe, Per
|
|
1992
|
26 |
4 |
p. 629-634
|
artikel
|
| 18 |
Predicting Anaphylactoid Reactions Based on Costart Terms
|
Rinsler, Steven S.
|
|
1992
|
26 |
4 |
p. 497-504
|
artikel
|
| 19 |
Reasonable Possibility: Causality and Postmarketing Surveillance
|
Johnson, Joyce M.
|
|
1992
|
26 |
4 |
p. 553-558
|
artikel
|
| 20 |
Software Survey Section
|
|
|
1992
|
26 |
4 |
p. i-iv
|
artikel
|
| 21 |
Strategies for Successfully Managing Pharmaceutical Research and Development in the 1990s
|
Drews, Jürgen
|
|
1992
|
26 |
4 |
p. 635-645
|
artikel
|
| 22 |
The Glaxo International Postmarketing Surveillance System: Present and Future
|
Phillips, George
|
|
1992
|
26 |
4 |
p. 527-535
|
artikel
|
| 23 |
The Italian Multicenter Trial on Prevention and Treatment of Benzodiazepine Withdrawal: Methodology and Pretrial
|
Cassano, Giovanni B.
|
|
1992
|
26 |
4 |
p. 615-627
|
artikel
|
| 24 |
The Passport to Drug Approval
|
Teijgeler, C. A.
|
|
1992
|
26 |
4 |
p. 655-657
|
artikel
|
| 25 |
The Pharmaceutical Industry on the Continent — A 10-Year Perspective since Morges
|
Venulet, Jan
|
|
1992
|
26 |
4 |
p. 603-608
|
artikel
|
| 26 |
The Who Database—I
|
Edwards, I. Ralph
|
|
1992
|
26 |
4 |
p. 477-480
|
artikel
|
| 27 |
The Who Database—II
|
Edwards, I. Ralph
|
|
1992
|
26 |
4 |
p. 481-486
|
artikel
|
| 28 |
WAES*NET — Merck's International AE Reporting System
|
Sromovsky, Judith A.
|
|
1992
|
26 |
4 |
p. 545-548
|
artikel
|
Tijdschrift beschrijving